BRIEF: Tech stocks shine in Hang Seng Composite review, consumer and pharma lag

Hong Kong’s benchmark Hang Seng Index (HSI) remained unchanged at 83 constituents in the compiler’s latest adjustments, while the Hang Seng Composite Index’s (HSCI) constituents dropped from 517 to 505 as 41 companies were removed. Notably, multiple companies related to artificial intelligence (AI) and autonomous driving were added, reflecting the current market focus, according to Hang Seng Indexes Co.’s announcement of its latest quarterly review last Friday.

The latest adjustment saw HSCI add several AI, autonomous driving, and robotics-related companies, including Horizon Robotics (9660.HK), InnoScience (2577.HK), Minieye Technology (2431.HK), and Dobot (2432.HK). Concurrently, several traditional consumer and pharmaceutical stocks were removed, including Nayuki Holdings (2150.HK), Pagoda Group (2411.HK), Helens International (9869.HK), CARsgen Therapeutics (2171.HK) and Tigermed Consulting (3347.HK). At the same time, recently listed consumer stocks Xiaocaiyuan (0999.HK) and Mao Geping (1318.HK) were included.

The Hang Seng Tech Index (HSTECH) saw Tencent Music (1698.HK) and Horizon Robotics added, while ZhongAn Online (6060.HK)and East Buy (1797.HK) were dropped. Meanwhile, the Hang Seng China Enterprises Index (HSCEI) added ZTO Express (2057.HK)and BeiGene (6160.HK), while Sino Biopharma (1177.HK)and Li Ning (2331.HK) were removed. All changes take effect on March 10.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click  here